This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwiatkowski, B.
Right arrow Articles by Schubach, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwiatkowski, B.
Right arrow Articles by Schubach, W. H.

 Previous Article  |  Next Article 

Journal of Virology, June 2004, p. 6067-6072, Vol. 78, No. 11
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.11.6067-6072.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation

Bogaslaw Kwiatkowski,1 Szu Yu Jenny Chen, and William H. Schubach1,2*

Division of Oncology, Department of Medicine, VA Puget Sound Health Care System, and Department of Medicine, University of Washington,1 Fred Hutchinson Cancer Research Center, Seattle, Washington2

Received 14 October 2003/ Accepted 27 January 2004

Substitution mutagenesis of EBNA2 shows that its interaction with hSNF5/Ini1 involves two sites (286IPP and DQQ313), and a mutation at a CKII phosphorylation site (SS469) is essential for the interaction. An alanine substitution (SS469AA) prevents binding to EBNA2 and diminishes the growth-promotion potential of EBNA2 in the transcomplementation assay.


* Corresponding author. Mailing address: VA Puget Sound Health Care System, S-111-ONC, 1660 S. Columbian Way, Seattle, WA 98108. Phone: (206) 764-2681. Fax: (206) 764-2851. E-mail: wschu{at}u.washington.edu.


Journal of Virology, June 2004, p. 6067-6072, Vol. 78, No. 11
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.11.6067-6072.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Boese, A., Sommer, P., Holzer, D., Maier, R., Nehrbass, U. (2009). Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity. J. Gen. Virol. 90: 2503-2512 [Abstract] [Full Text]  
  • Yue, W., Shackelford, J., Pagano, J. S. (2006). cdc2/Cyclin B1-Dependent Phosphorylation of EBNA2 at Ser243 Regulates Its Function in Mitosis. J. Virol. 80: 2045-2050 [Abstract] [Full Text]  
  • Yue, W., Gershburg, E., Pagano, J. S. (2005). Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter. J. Virol. 79: 5880-5885 [Abstract] [Full Text]  
  • Peng, R., Moses, S. C., Tan, J., Kremmer, E., Ling, P. D. (2005). The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter. J. Virol. 79: 4492-4505 [Abstract] [Full Text]